2m 2m 2m 2m 2m 2m 2m
CG ONCOLOGY (CGON)
NASDAQ
$65.87+$0.13 (+0.21%)
Price as of Jun 23, 2026 5:01 PM EDT- $5.8BMarket Cap
- 154.77%1-Year Change
- BiotechnologyIndustry
CG ONCOLOGY (CGON)
$65.87+$0.13 (+0.21%)
CGON | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $65.73 | ||
Change | -$0.52 (-0.78%) | ||
Open | $64.82 | ||
High | $66.69 | ||
Low | $63.75 | ||
Previous Close | $66.25 | ||
Volume | 846,606 | ||
30-Day Average Volume | 1,027,437 | ||
1-Week Change | 9.04% | ||
1-Month Change | 2.30% | ||
1-Year Change | 154.77% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 88.2M | ||
Total Assets | $1.1B | ||
Market Cap | $5.8B | ||
Enterprise Value | $5.8B | ||
Period: QTR TTM FY | |||
Revenue | $1.1M | ||
Net Income | -$60.2M | ||
Free Cash Flow | -$57.2M | ||
EBIT | -$60.2M | ||
EBITDA | -$59.4M | ||
Net Working Capital | $1.1B | ||
EPS | -$0.71 | ||
Enterprise Value/EBITDA | -98 | ||
Enterprise Value/Revenue | 5,438 | ||
P/B | 5 | ||
P/E | -93 | ||
PEG | 2 | ||
Price/Free Cash Flow | -102 | ||
Price/Operating Cash Flow | -103 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue